National Allergies, Immunotherapy and RhinoConjunctivitis Survey in America

Percentage of Participants Who Received Immunotherapy to Treat ARC

时间窗: Within 12 months prior to survey

Participants who had ever received immunotherapy for ARC were asked about the type of immunotherapy - subcutaneous or sublingual - received. The percentage of participants who received immunotherapy to treat ARC was calculated.

Percentage of Participants Who Used Medication to Treat ARC in the Past 12 Months

时间窗: Within 12 months prior to survey

Participants were asked about prescription and over-the-counter medication use for ARC. The percentages of participants who used prescription and/or over-the-counter medication to treat ARC in the past 12 months were calculated.

Percentage of Participants Who Experienced Daily Symptoms Due to Allergic Rhinoconjunctivitis (ARC)

时间窗: Within 12 months prior to survey

Participants were asked about the frequency and severity of ARC symptoms when allergies were at their worst. The percentages of participants who experienced different symptoms of ARC on a daily basis when allergies were at their worst were calculated.

Percentage of Participants Who Experienced Work or School Absence Due to ARC in the Past 12 Months

时间窗: Within 12 months prior to survey

Participants were asked about the impact of ARC on loss of work and school time. The percentage of participants who experienced work or school absence due to ARC in the prior 12 months was calculated.

Percentage of Participants Who Received Allergy Shots and Required Supplemental Prescription Allergy Medication

时间窗: Within 12 months prior to survey

Participants who received subcutaneous immunotherapy (allergy shots) were asked about prescription and over-the-counter medication use. The percentage of participants who received allergy shots to treat ARC, had not taken over-the-counter allergy medication and required supplemental prescription allergy medication for ARC was calculated.